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ABSTRACT 
Acellular dermal matrix (ADM) has revolutionised implant based breast 
reconstruction. Breast reconstruction has evolved from the traditional sub-muscular 
to the new pre-pectoral implant based (also known as muscle-sparing) 
reconstruction. The new technique is emerging as a highly popular surgery due to its 
more minimal approach.  We conducted a narrative review to guide pre-pectoral 
breast reconstruction highlighting the technique, need for appropriate patient 
selection, and areas for further research.  We show that pre-pectoral breast 
reconstruction is safe, feasible, and has excellent short term outcomes (cosmesis 
and patient satisfaction).  Its main advantages are that it avoids animation 
deformity, prevents shoulder dysfunction, and has a lower incidence of capsular 
contracture.  Selection for the pre-pectoral technique is dependent on patient 
factors (e.g. BMI, lifestyle), breast size, flap assessment, and adjuvant radiotherapy.  
Whilst the initial short-term results are promising, long-term outcomes are yet to be 
reported and is an area that requires further research. 
 
Keywords: acellular dermis; Breast; Breast Implants; mastectomy; pectoralis 
muscles.  
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BACKGROUND: EVOLUTION OF PRE-PECTORAL BREAST RECONSTRUCTION 
Breast cancer is the most common malignancy in women in the United Kingdom 
(UK), with four in ten women undergoing a mastectomy as their primary therapeutic 
procedure.1 Implant-based breast reconstructions account for 40-60% of all breast 
reconstructions performed in the UK and approximately 75% in the United States 
(US).2–4 
 
A variety of options are available for breast reconstruction: autologous, prosthetic 
(implant-based), or a hybrid of the two.  Implant-based reconstruction is the most 
common pathway with approximately 70% of all breast reconstructions being 
prosthetic based, often as a single stage process in the UK & Europe or as a two-
staged process in the US: the first stage involving a tissue expander and a second 
stage where the expander is exchanged for a prosthetic breast implant.5–7 
 
In 1882, the Halstead radical mastectomy was pioneered; since then, a more 
conservative approach is being favoured in which the skin and/or nipple are 
spared.8,9   The native breast envelope and inframammary fold is favoured, allowing 
reconstruction at the time of mastectomy with a highly favourable cosmesis.10,11   
Whilst some believed a more conservative approach compromised oncological 
safety, further studies have shown this not to be the case.11,12 
 
Indeed, over time, oncologic therapies as well as the reconstructive tools and 
principles have evolved: tissue expanders, prosthetic implant devices, implements 
for flap perfusion assessment, bioprostheses, and the combination of reconstruction 
techniques with fat grafting have all been refined, allowing for improved surgical 
outcomes.13 
 
Over the last decade, the introduction of meshes has revolutionised breast 
reconstruction. A wide variety of biological and synthetic meshes are available;14–16 a 
biological mesh, referred to as an acellular dermal matrix (ADM), is a scaffold of 
dermis from either cadaveric human (Alloderm®, Allomax®, FlexHD®, DermaCell®), 
porcine (Strattice®, Permacol™, Braxon®), bovine (SurgiMend®), or bovine 
pericardium (Veritas®) tissue.   They are made devoid of their cell content and 
sterilised; as such, are considered to be non-inflammatory.  The biological scaffold 
allows rapid host revascularisation and cell repopulation arguably facilitating a good 
surgical outcome. 
 
Most studies have reviewed biological matrices in implant-based reconstruction, 
acting as an extension of the pectoralis major.17,18  It is attached to the inferior-
lateral pole of the muscle, the mesh expands the space available for the insertion of 
an implant, filling the void left between the muscle and fascia, creating a natural 
infra mammary fold (Figure 1a).19 This technique provides additional cover and 
support inferiorly, enabling faster tissue expansion, larger implant volumes, and 
improvement of lower pole projection.20 
 
Synthetic matrices are also being used in breast reconstruction as an alternative to 
ADMs.19 These are made from plastic-like material: absorbable (Vicryl), long-term 
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absorbable (TIGR®), or non-absorbable (titanium-coated polypropylene mesh 
(TiLOOP®). 
 
In the traditional sub-muscular breast reconstruction, the technical employment is 
based on the principle of implant lower lateral pole coverage in a hammock-like 
fashion after pectoralis major detachment.21   However, its disadvantaged by the 
potential impairment to shoulder dysfunction and animation deformity due to its 
detachment .22  As such, a more novel pre-pectoral approach is being employed 
more often to avoid such a complication.   
 
Pre-pectoral breast reconstruction involves creating a new breast (Figure 1b), 
constructed ex-vivo by covering the implant with the mesh and subsequently 
attaching it over the chest wall, thereby keeping the pectoralis major and serratus 
anterior undisturbed. It ensures that the breast remains in its anatomical plane, 
minimising morbidity, achieving the desired cosmesis, and maintaining shoulder 
functionality.  
PATIENT SELECTION 
Appropriate patient selection is vital for a good outcome of pre-pectoral breast 
reconstruction particularly during the initial learning curve.  The senior author of this 
paper in her series of pre-pectoral breast reconstruction23 selected patients in 
accordance to the Joint guidelines by the Association of Breast Surgeons (ABS) and 
the British Association of Plastic, Reconstruction and Aesthetic surgeons (BAPRAS).24  
Patients with minimal comorbidity, an active lifestyle, small to medium sized breasts, 
good intra-operative tissue perfusion would be good candidates for this surgery 
(Figure 2).  Important selection criteria include: 
 
• Pre-operative selection is important: patients with a low BMI (< 35kg/m2), 
non- or ex- smokers, grade 1 or 2 ptosis, or anticipated breast volume of 
resection less than 500 grams would be more ideal to minimise complications 
and achieve the desired outcome.  
• Patient lifestyle should be taken into consideration, particularly athletes who 
require extensive pectoralis major use and require preserved shoulder 
functionality.  
• Tumour histopathology would dictate the requirement for adjuvant therapy. 
There is currently limited data on toleration of adjuvant radiotherapy and its 
impact on meshes; it would be ideal to avoid the pre-pectoral technique in 
patients who require immediate post-operative radiotherapy. However in our 
experience the tolerability of post-operative radiotherapy was good, 
although our sample size was very small. 
• Intra-operative assessment of tissue perfusion is crucial, good perfusion of 
the mastectomy flaps is required for mesh integration. .   
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INDICATIONS 
The main indications for this technique are tabulated in Table 1, pre-pectoral based 
implant reconstruction following immediate mastectomy is likely to be the most 
common indication. It can also be used to treat undesirable outcomes following 
reconstructions including animation deformity, capsular contracture and breast 
deformity.  
 
SURGICAL TECHNIQUE 
Pre-operatively, the patient should undergo normal counselling (diagnosis and 
potential treatments and the associated risks & benefits).  During the operation, the 
type of scar would be influenced by the tumour location, surgeon’s preference and 
breast morphology.  The common incisions for nipple sparing or skin sparing 
mastectomy include inframammary, vertical or a lateral approach; non-nipple 
sparing includes the classic elliptical approach.  A good quality mastectomy flap is 
important for the success of the surgery.  In some centres, a close working 
relationship between the mastectomy and the reconstructive surgeon is successfully 
used to achieve this.  
 
Assessment of the vascularity and perfusion of the mastectomy flap can be done 
with clinical judgement or certain devices (e.g SPY system) . If the area is small it can 
be excised, otherwise consideration to alternatives needs to be given. 
 
The type of implants used can be fixed volume silicone or saline, anatomical or 
round depending on the need to match symmetry. If pressure on the skin flaps is 
possible then an adjustable flat expander implant can be used. The implant is placed 
under-filled, ensuring that there is no increased pressure to the flaps and expanded 
at a later date once viability of the flaps is confirmed.  
 
Drains, closure of the wound, and dressings can be placed according to local surgical 
practice.  The senior author used absorbable 2-0 vicryl for subcutaneous and 3-0 
monocryl for subcuticular skin closure in her series.23  
TYPES OF MESHES: PRE-PECTORAL BREAST RECONSTRUCTION 
Biological and non-biological meshes have been tabulated in Table 2. It is vital that 
the biological meshes have intimate contact with the vascularised tissue to promote 
remodelling of the collagen membrane and integrate into the tissues.25–27 
 
The only ADM mesh that is pre-shaped is Braxon® (Decomed S.r.l., Venezia, Italy). 
The other meshes are available as flat sheets, which are wrapped around the 
implant. These flat meshes are commonly used for sub-muscular reconstruction but 
are now being used in pre-pectoral breast reconstruction. 
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COMPLETE WRAP WITH A PRE-SHAPED MESH 
Braxon® is a pre-shaped, 0.6 mm thick, porcine, non-cross-linked ADM which 
requires hydration in saline; it is designed to wrap around implants ranging up to 500 
cc. The selected implant is placed and wrapped within the matrix with the edges 
suturing together with either continuous or interrupted absorbable sutures (2-0 
Vicryl) to form a tight pocket (Figure 3). This is subsequently placed onto the 
pectoralis without its detachment and anchored with apical, medial and lateral 
absorbable sutures directly on to the chest wall, allowing for neovascularisation to 
occur and incorporating the biomaterial into the surrounding tissues for a stable, 
permanent cover.  
COMPLETE WRAP WITH FLAT SHEET MESH 
The wrap-around of the mesh is carried using either a single large piece (if available) 
or two pieces of mesh anchored using sutures (Figure 4). The mesh forms a complete 
360 degree wrap around the implant and the mesh edges are sutured to form a 
pocket using an absorbable suture (e.g. 2-0 Vicryl or PDS). The mesh implant pocket 
is secured to the chest wall and, if needed, to the inframammary fold. This enables 
an adequate anchorage and control of the breast shape and ptosis, avoiding implant 
displacement.  
ANTERIOR WRAP WITH FLAT SHEET MESH 
An alternative option would be to undergo an anterior wrap of the mesh, covering 
the implant with subsequent fixation to the chest wall.  However, the literature 
reporting outcomes for this this technique is very limited.  It is also associated with 
implant displacement and implant herniation through the mesh due to the lack of 
posterior cover, and an inability to control the nipple position. It may also be 
associated with an increased risk of capsular contracture as a complete wrap of ADM 
has shown to treat capsular contracture and lessen the chance of its occurrence.28 
EXTENSION OF THE TECHNIQUE 
The technique can be extended to patients with large, ptotic breasts (preferably 
once crossing the learning curve) with or without incorporating the dermal flap.  The 
dermal flap provides additional soft tissue coverage and can enhance the volume of 
the reconstructed breast. The dermal flap along with the mesh forms a pocket for 
the implant, which is placed pre-pectorally. Caputo et al demonstrated this 
technique in 27 patients (33 breasts) and observed no implant loss with a low 
number of skin necroses.29 
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COST  
The cost of the meshes varies across countries and in Europe.  On average, biological 
ADM meshes cost: 
• 8x16cm piece (128 cm2): £1,600 - £1,800  
• 10x18cm piece (180 cm2): £2,200 - £2,500 
• the pre-shaped Braxon® mesh 30x20cm (600 cm2): £2,100 
• Biological allograft meshes in the US appropriately cost: $3000  
 
Synthetic meshes are cheaper with 20X16cm at approximately €500 (~£400) but 
usually two meshes are required to form a complete wrap. 
 
MESH INTEGRATION 
The biological mesh gets integrated through collagen remodelling and this ultimately 
integrates with the host tissues and get vascularised.26 Biological grafts have 
collagen matrix, which aids in remodelling and new collagen deposition.30 The 
characteristics of the material are dictated by the origin of the tissue derived. The 
chemical processing would influence its inert nature and the host response.  The 
nature of biological meshes integration is believed to generate minimal foreign body 
reaction.   
 
The synthetic meshes create a scaffold and promote fibrous tissue growth.  The 
integration is influenced by the porosity, elasticity and the type of material.  Our 
knowledge, extrapolated from hernia surgery, revealed that knitted meshes are 
more porous while woven ones are stronger. The synthetic meshes integrate with a 
fibroblastic reaction; the microscopic appearance of the titanium-coated synthetic 
mesh integration within a capsule (titanium-coated polypropylene mesh) alongside a 
mild chronic inflammatory response; all of which are completely integrated within 
fibroblastic tissue.29 
 
WHICH MESH TO CHOOSE? 
The choice is mesh will largely depend on the surgeon’s choice, its availability, and 
cost.  The latter being a major factor in an era of financial constraint. However, due 
to the heterogeneous nature of the products, direct comparisons are difficult.  
Consequently, a good understanding of the products is essential to inform choice in 
clinical practice.  
 
One should also consider that biological meshes integrate through collagen 
remodelling and this property of neo-tissue formation results in effective implant 
cover; indeed, this may offset the higher cost when compared to synthetic meshes.  
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DISCUSSION 
The use of a whole muscular pocket for prosthesis coverage to prevent wound 
dehiscence and implant exposure has been the preferred choice until recently.30  
However, the field of implant-based breast reconstruction has been radically 
changed since the introduction of meshes, resulting in adoption of new techniques.  
 
One stage mesh based sub-muscular breast reconstruction offers a major advantage 
with immediate reconstruction. However the problems associated with shoulder 
dysfunction, postoperative pain, and animation deformity has led to the emergence 
of the novel pre-pectoral (muscle sparing) technique. 
 
The effectiveness of muscle-sparing breast reconstruction technique using a 
complete ADM implant coverage has been demonstrated in a large series by the 
senior author in her series.23 While other authors have shown its effectiveness using 
either partial ADM breast implant cover or complete coverage using synthetic 
meshes 20,25. This technique preserved the natural anatomy, provided complete 
cover and avoided direct implant contact with the mastectomy flaps.  
 
In 2015, a non-randomised prospective trial compared the long-term outcomes for 
retropectoral and pre-pectoral breast reconstructions (n=63) for a median follow-up 
of 26 (range: 16-42) months and 25 (16-40) months, respectively.32  They reported 
similar results with no differences in terms of short- or long- term surgical 
complications or sexual well-being  but did report a greater satisfaction with 
outcome in the pre-pectoral group (p=0.03) (again, with BREAST-Q).32  Indeed, the 
small sample size and non-randomisation nature of the study means that the results 
should be interpreted cautiously; nevertheless, it is one of the few studies to 
compare the two techniques.  
 
The pre-pectoral technique using the Braxon® ADM was performed by the senior 
author in her series.23  It was associated with low rate of complications which could 
be due to appropriate patient selection and surpassing the learning curve associated 
with meshes.  The advantage of using the pre-shaped ADM matrix included adoption 
of a standard technique with a short learning curve and a favourable outcome. 
Perhaps this is because pre-pectoral placement of the implant simulates the natural 
position of the removed breast tissue, leading to a more natural feel.   
 
In 2015, a non-randomised prospective trial compared the long-term outcomes for 
retropectoral and pre-pectoral breast reconstructions (n=63) for a median follow-up 
of 26 (range: 16-42) months and 25 (16-40) months, respectively.32  They reported 
similar results with no differences in terms of short- or long- term surgical 
complications or sexual well-being  but did report a greater satisfaction with 
outcome in the pre-pectoral group (p=0.03) (again, with BREAST-Q).32.  Indeed, the 
small sample size and non-randomisation nature of the study means that the results 
should be interpreted cautiously; nevertheless, it is one of the few studies to 
compare the two techniques.  
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The incidence of capsular contracture reported varies between 2.8 to 15.9 % with an 
increase in incidence following adjuvant radiotherapy. A technique has been 
described using ADM coverage to treat and prevent capsular contracture with no 
recurrence in capsular contracture (n=11) over an average follow-up of 9.2 (range: 
2.4-18.8) months.33  Previous partial implant coverage using ADM has showed to 
result in a recurrence rate of 6.3% However, the observational nature and small 
sample size limit this study.  However, the pre-pectoral technique with complete 
cover may be useful in preventing and treating capsular contracture. 
 
Rippling could be a problem associated with the pre-pectoral technique.  
Lipomodelling can be used to successfully treat rippling, as shown by Becker et al. 
where it was used successfully in 6.4% of his patients.34  He also observed that 
rippling was due to the use of saline implants which were changed to silicone in 9 
patients (29%). The senior author observed no major rippling requiring intervention 
in her series with a mean follow up of 13.9 (range: 8.5-20.7) months.23 
 
Thus, the muscle-sparing reconstructive technique preserves the natural anatomy 
thereby avoiding the adverse effects associated with sub-muscular reconstruction. 
These include preservation of shoulder function, minimising postoperative pain and 
the lack of animation deformity.29 It is evident that implant based reconstruction 
constitutes a majority of the reconstruction practice in the US, UK and Europe and 
the pre-pectoral technique adds a whole new dimension. 
 
CONCLUSION 
It seems, then, that the pre-pectoral breast reconstruction is safe and feasible.  Its 
main advantages are that it avoids animation deformity, prevents shoulder 
dysfunction, and has a lower incidence of capsular contracture.  However, it may 
cause rippling which can require further intervention (e.g. lipomodelling) although 
this is not specific to the pre-pectoral technique.  With its relatively short learning 
curve and promising short-term outcomes, it seems to be a promising technique, 
however, further research looking at the long term follow-up is required to assess 
the aesthetic outcomes and long term morbidity that it may be associated with. 
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TABLES: 
Table 1: Indications for pre-pectoral breast reconstruction 
Pre-pectoral breast reconstruction: indications 
• Immediate breast reconstruction  
• Immediate delayed breast reconstruction 
• Breast revision surgery for 
o Animation deformity 
o Capsular contracture 
o Breast deformity 
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Table 2: Types of meshes 
ADM: acellular dermal matrix 
  
Type of Mesh Types Form Availability 
ADM: Porcine  
• Braxon® (Decomed S.r.l., 
Venezia, Italy) 
 
• Strattice™ (Lifecell, 
Branchburg, New Jersey, 
USA) 
 
 
Porcine derived 
 
Pre-shaped ADM 
 
 
Flat sheet 
 
UK, Europe 
 
 
UK, Some part of 
Europe, US  
ADM: Foetal Bovine 
 
• SurgiMend (TEI 
Biosciences, Boston, 
Massachusetts, USA) 
 
 
 
Bovine derived 
 
 
Flat sheet 
 
 
UK, Some part of 
Europe, US 
Synthetic mesh 
 
• TiLOOP Bra (PFM Medical, 
Cologne, Germany) 
 
 
• TIGR Matrix Surgical 
Mesh (Novus Ltd, 
Singapore) 
 
 
 
• Knitted Vicryl Mesh 
(Vicryl, Ethicon, New 
Jersey, USA) 
 
 
Titanium coated 
polypropylene 
mesh 
 
copolymer of 
glycolide and 
trimethylene 
carbonate 
 
Polyglactin 910 
 
 
Flat sheet 
 
 
 
Flat sheet 
 
 
 
 
Flat sheet 
 
 
Mainly in UK, 
Europe 
 
 
Mainly in UK, 
Europe 
 
 
 
Mainly in US,  and 
some part of 
Europe 
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FIGURES 
 
Figure 1a (left): demonstrates the pectoral muscle and the mesh which forms the 
pocket for the implant which is placed sub-pectorally; 1b (right): demonstrates the 
mesh which forms the pocket for the implant which is placed pre-pectorally. 
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Figure 2: Patient selection criteria 
  
•No anticipated 
radiotherapy
•Good flap 
thickness
•Adequate 
tissue 
Perfusion
•Ptosis grade 1 or 2
•Anticipated 
resection weight 
<500grams
•Choice (athletic 
requirements)
•Non- or ex-
smoker
•BMI <35
Patients Breasts
Tumour
Intra 
operative
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Figure 3: Pre-shaped Braxon® mesh wrapped around the implant 
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Figure 4: Mesh cover for the implant with synthetic mesh (Tiloop®): a) flat mesh; b) 
edges of the mesh are sutured; c) implant covering with the mesh as the mesh forms 
a close fitting wrap  
 
